Why is psychotherapy delivered in videoconference as effective as in face to face in the treatment of panic disorder with agoraphobia?”

Not Applicable

Completed

• Conditions: Panic Disorder and agoraphobia treated through videoconference; Mental and Behavioural Disorders

• Registration Number: ISRCTN76456442
• Lead Sponsor: niversity of Quebec at Outaouais (Université du Québec en Outaouais (UQO)) (Canada)

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32973638/ (added 28/09/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2006-05-08
• Study Start: 2014-12-10
• Last Update Posted: 12 October 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 71

Inclusion Criteria

1. Ambulatory man and woman
2. At least 18 years old and at most 65 years old
3. French speaking
4. Receiving a principal diagnosis of PDA based on DSM-IV diagnostic criteria. Assessed with a semi-structured diagnostic interview (SCID-I)
5. If currently taking medication for PDA, pharmacotherapy must me stabilized (same type and dosage) for at least three months and the PDA remained stable and uncured (i.e. still meeting the diagnostic criteria). Note that there is no perfect solution to the problem of medication since most severe cases already receive Selective Serotonin Reuptake Inhibitor (SSRI) from their doctors when they seek psychological treatments (thus, recruiting non-medicated participants would
threaten the feasibility of the study and could lead to the selection of less severe cases) and stopping medication would induce other methodological problems (e.g., withdrawal symptoms, artificial peak of severity at pre-treatment, ethical issues).

Exclusion Criteria

1. Having a principal diagnosis other than PDA
2. Currently suffering from a severe organic disease, dementia, mental retardation, schizophrenia, amnesia, substance abuse, borderline personality disorder, psychosis or bipolar disorder
3. PDA being secondary to a medical condition
4. Active suicidal ideations
5. Starting a new medication or changing actual medication
6. Receiving another psychotherapy to treat PDA in the last 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Severity of PDA symptoms. The degree of severity of panic disorder and agoraphobia was assessed by the participant with the Panic and Agoraphobia Scale (PAS). The PAS contains 13 items with 0-4-point scales grouped in five subscales: panic attacks (frequency, severity, and duration), avoidance, anticipatory anxiety, disability (family, social, employment), and worries about health. The total score is obtained by summing the item scores.